Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Obesity increases the risk of type 2 diabetes, cardiovascular diseases, and certain cancers, which are among the leading causes of death worldwide. Obesity and obesity-related metabolic diseases are characterized by specific alterations in the human gut microbiota. Experimental studies with gut microbiota transplantations in mice and in humans indicate that a specific gut microbiota composition can be the cause and not just the consequence of the obese state and metabolic disease, which suggests a potential for gut microbiota modulation in prevention and treatment of obesity-related metabolic diseases. In addition, dietary intervention studies have suggested that modulation of the gut microbiota can improve metabolic risk markers in humans, but a causal role of the gut microbiota in such studies has not yet been established. Here, we review and discuss the role of the gut microbiota in obesity-related metabolic diseases and the potential of dietary modulation of the gut microbiota in metabolic disease prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“It has been reported that the obesity epidemic is leveling off in certain European countries and in the United States (2, 3), but even when the slower growth is taken into consideration, it has been estimated that ;42% of the adult US population will be obese in 2030 (4).”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 2×
“The second most prevalent phylum, the Bacteroidetes, comprises gram-negative bacteria from ;20 genera, including Bacteroides, Odoribacter, Prevotella, and Tannerella (28).”
BackgroundGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 3×
“It is possible that TABLE 1 Association between the gut microbiota and obesity1 Study (reference) Description Results Le Chatelier et al. 2013 (17) Danish obese (n = 169) and nonobese (n = 123) adults; case-control; metagenomics 15,894 bacterial genes differed between groups.”
BackgroundInfluentialGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 1×
“Larsen et al. 2010 (114) Danish adults with T2D (n = 18) and healthy controls (n = 18); pyrosequencing Firmicutes including Clostrida reduced in T2D.”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“The microbiota has also been suggested to suppress the expression of AMP-activated protein kinase, which leads to decreased fatty acid oxidation in muscles (95), and to suppress the expression of angiopoietin-related protein 4, which leads to increased TG storage in the liver and adipose tissue (92, 96, 97).”
BackgroundSuccession of microbial consortia in the developing infant gut microbiome
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · cited 1×
“During the first 3 y of life, the microbial diversity increases to reach a level similar to adulthood (33, 34).”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 5×
“L. paracasei negatively correlated with FBG. L. fermentum marginally negatively correlated with FBG. Schwiertz et al. 2010 (112) German obese and nonobese adults (n = 98); cross-sectional; qPCR Firmicutes (mainly C. leptum) reduced and Bacteriodetes (mainly Bacteroides) increased in overweight and obesity.”
BackgroundInfluentialHost Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Kling Bäckhed, H., Gonzalez, A., Werner, J. J., Angenent, L. T., Knight, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.008 · Cited by 2,165 · cited 1×
“This is demonstrated by the altered gut microbiota in pregnancy (36), inflammatory bowel diseases (25), obesity (13), T2D (14, 37), atherosclerosis (15), and NAFLD (16).”
BackgroundThe Long-Term Stability of the Human Gut Microbiota
Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A. L., Clemente, J. C., Knight, R., Heath, A. C., Leibel, R. L., et al. (2013) · Science · doi:10.1126/science.1237439 · Cited by 2,058
Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans
Muegge, B. D., Kuczynski, J., Knights, D., Clemente, J. C., González, A., Fontana, L., Henrissat, B., Knight, R., & Gordon, J. I. (2011) · Science · doi:10.1126/science.1198719 · Cited by 1,988 · cited 1×
“The overall composition of the diet also has a major impact on the gut environment shown by the imprint of longterm dietary intake on the microbiota (34, 65, 66), the changes in the microbiota after shifts in macronutrient composition (67), intake of animal- compared with plant-based diets (68), and after energy restr…”
BackgroundRegulation of short-chain fatty acid production
Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
The control and consequences of bacterial fermentation in the human colon
Cummings, J. H., & Macfarlane, G. T. (1991) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1991.tb02739.x · Cited by 1,499
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371
Bile Salt Hydrolase Activity in Probiotics
Begley, M., Hill, C., & Gahan, C. G. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.3.1729-1738.2006 · Cited by 1,187
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974
Duncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M., Flint, H. J., & Lobley, G. E. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02340-06 · Cited by 941
Armougom, F., Henry, M., Vialettes, B., Raccah, D., & Raoult, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007125 · Cited by 905 · cited 3×
“2009 (113) French adolescents and adults with obesity (n = 20) or anorexia nervosa (n = 9) and healthy controls (n = 20); case-control; qPCR Bacteroidetes and Lactobacillus species increased in obesity compared to normal- and underweight.”
BackgroundZoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., & de Vos, W. M. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.7.3401-3407.2002 · Cited by 868 · cited 1×
“However, comparisons of microbiota from mucosal biopsies and stool samples have shown that there are compositional differences between the mucosa-associated and the luminal (fecal) microbiota (99).”
BackgroundDiets with high or low protein content and glycemic index for weight-loss maintenance
Larsen, T. M., Dalskov, S.-M., van Baak, M., Jebb, S. A., Papadaki, A., Pfeiffer, A. F. H., Martinez, J. A., Handjieva-Darlenska, T., Kunešová, M., Pihlsgård, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007137 · Cited by 843 · cited 2×
“Randomized controlled dietary interventions with high protein (HP) content and low glycemic index (LGI) have been shown to enhance weight loss and weight maintenance in overweight and obese adults (85, 86).”
BackgroundSelf-citationWalker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W., & Flint, H. J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.7.3692-3700.2005 · Cited by 796
Russell, W. R., Gratz, S. W., Duncan, S. H., Holtrop, G., Ince, J., Scobbie, L., Duncan, G., Johnstone, A. M., Lobley, G. E., Wallace, R. J., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002188 · Cited by 775
Relevance of protein fermentation to gut health
Windey, K., De Preter, V., & Verbeke, K. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100542 · Cited by 692 · cited 1×
“However, HP diets have been hypothesized to be harmful for colonic health because they lead to increased fermentation of undigested protein in the colon, which produces potential harmful metabolites, such as ammonia, phenols, hydrogen sulfide, and amines (71, 87, 88).”
BackgroundRaman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · cited 6×
“Obesity represents a major health risk because it can lead to impaired quality of life (5) and increased risk of a wide range of diseases including type 2 diabetes (T2D)2 (6), cardiovascular diseases (7), nonalcoholic fatty liver disease (NAFLD) (8), and certain types of cancer (9).”
BackgroundInfluentialChylomicrons promote intestinal absorption of lipopolysaccharides
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., & Eckhardt, E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800156-jlr200 · Cited by 662
Rabot, S., Membrez, M., Bruneau, A., Gérard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R., & Chou, C. J. (2010) · The FASEB Journal · doi:10.1096/fj.10.164921 · Cited by 610
Rokholm, B., Baker, J. L., & Sørensen, T. I. A. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00810.x · Cited by 601 · cited 1×
“It has been reported that the obesity epidemic is leveling off in certain European countries and in the United States (2, 3), but even when the slower growth is taken into consideration, it has been estimated that ;42% of the adult US population will be obese in 2030 (4).”
BackgroundKaczmarczyk, M. M., Miller, M. J., & Freund, G. G. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.017 · Cited by 554 · cited 1×
“Dietary fibers induce several health effects that are similar to the function of prebiotics, such as stimulation of SCFA production and regulation of glucose and lipid metabolism (59), and it can be difficult to assess whether beneficial metabolic functions can be attributed to a dietary fiber per se or to a prebiotic…”
BackgroundShort-chain fatty acids: ready for prime time?
Roy, C. C., Kien, C. L., Bouthillier, L., & Levy, E. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021004351 · Cited by 443
Techniques used to characterize the gut microbiota: a guide for the clinician
Fraher, M. H., O'Toole, P. W., & Quigley, E. M. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.44 · Cited by 385
Intestinal Permeability Defects: Is It Time to Treat?
Odenwald, M. A., & Turner, J. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.001 · Cited by 366
Vulevic, J., Juric, A., Tzortzis, G., & Gibson, G. R. (2013) · The Journal of Nutrition · doi:10.3945/jn.112.166132 · Cited by 349
Ul‐Haq, Z., Mackay, D. F., Fenwick, E., & Pell, J. P. (2013) · Obesity · doi:10.1002/oby.20107 · Cited by 311 · cited 1×
“Obesity represents a major health risk because it can lead to impaired quality of life (5) and increased risk of a wide range of diseases including type 2 diabetes (T2D)(2) (6), cardiovascular diseases (7), nonalcoholic fatty liver disease (NAFLD) (8), and certain types of cancer (9).”
BackgroundDue, A., Toubro, S., Skov, A. R., & Astrup, A. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802767 · Cited by 305 · cited 1×
“Randomized controlled dietary interventions with high protein (HP) content and low glycemic index (LGI) have been shown to enhance weight loss and weight maintenance in overweight and obese adults (85, 86).”
BackgroundSelf-citationJones, M. L., Martoni, C. J., & Prakash, S. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.126 · Cited by 277
Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
Brahe, L. K., Astrup, A., & Larsen, L. H. (2013) · Obesity Reviews · doi:10.1111/obr.12068 · Cited by 264 · cited 1×
“Butyrate is of particular interest for gut barrier function because it is preferred over other SCFAs as nutrient for the colonocytes, and because it appears to enhance gut barrier function by regulation of TJ proteins and mucins (48).”
BackgroundSelf-citationLecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262
Moreno-Navarrete, J. M., Ortega, F., Serino, M., Luche, E., Waget, A., Pardo, G., Salvador, J., Ricart, W., Frühbeck, G., Burcelin, R., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.256 · Cited by 223
Immunomodulation by commensal and probiotic bacteria
Forsythe, P., & Bienenstock, J. (2010) · Immunological Investigations · doi:10.3109/08820131003667978 · Cited by 189
Gögebakan, Ö., Kohl, A., Osterhoff, M. A., van Baak, M. A., Jebb, S. A., Papadaki, A., Martinez, J. A., Handjieva-Darlenska, T., Hlavaty, P., Weickert, M. O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.033274 · Cited by 180
Self-citationFuentes, M. C., Lajo, T., Carrión, J. M., & Cuñé, J. (2013) · British Journal of Nutrition · doi:10.1017/s000711451200373x · Cited by 174
Gordon, J. I. (2012) · Science · doi:10.1126/science.1224686 · Cited by 172 · cited 1×
“Probiotics are living microorganisms that, when ingested, provide health benefits, either directly through interactions with host cells or indirectly through effects on other bacterial species (61).”
BackgroundBrahe, L. K., Le Chatelier, E., Prifti, E., Pons, N., Kennedy, S., Blædel, T., Håkansson, J., Dalsgaard, T. K., Hansen, T., Pedersen, O., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515001786 · Cited by 171 · cited 7×
“Interventions with different types of dietary fibers including prebiotics have been shown to modulate the gut microbiota and improve insulin sensitivity, low-grade chronic inflammation, and lipid metabolism (18, 19, 124, 128).”
BackgroundInfluentialSelf-citationThe adult intestinal core microbiota is determined by analysis depth and health status
Salonen, A., Salojärvi, J., Lahti, L., & de Vos, W. M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03855.x · Cited by 114 · cited 1×
“This is interesting because this more variable microbiome appears to be vulnerable to environmental factors, such as diet and drugs, to a higher degree than the core microbiome (40).”
BackgroundCurrent level of consensus on probiotic science-Report of an expert meeting-London, 23 November 2009
Rowland, I. R., Capurso, L., Collins, K., Cummings, J., Delzenne, N., Goulet, O., Guarner, F., Marteau, P., & Meier, R. (2010) · Gut Microbes · doi:10.4161/gmic.1.6.13610 · Cited by 109
Intestinal microflora and metabolic diseases
Serino, M., Luche, E., Chabo, C., Amar, J., & Burcelin, R. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.003 · Cited by 77 · cited 1×
“The microbiota has also been suggested to suppress the expression of AMP-activated protein kinase, which leads to decreased fatty acid oxidation in muscles (95), and to suppress the expression of angiopoietin-related protein 4, which leads to increased TG storage in the liver and adipose tissue (92, 96, 97).”
BackgroundTreating diabetes and prediabetes by focusing on obesity management
Khaodhiar, L., Cummings, S., & Apovian, C. M. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0055-0 · Cited by 56 · cited 1×
“Obesity represents a major health risk because it can lead to impaired quality of life (5) and increased risk of a wide range of diseases including type 2 diabetes (T2D)(2) (6), cardiovascular diseases (7), nonalcoholic fatty liver disease (NAFLD) (8), and certain types of cancer (9).”
Background
Cited by
Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome
Sze, M. A., & Schloss, P. D. (2016) · mBio · doi:10.1128/mbio.01018-16 · Cited by 600
Cuevas-Sierra, A., Ramos-Lopez, O., Riezu-Boj, J. I., Milagro, F. I., & Martinez, J. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy078 · Cited by 523
McNabney, S., & Henagan, T. (2017) · Nutrients · doi:10.3390/nu9121348 · Cited by 508
Differences in gut microbiota profile between women with active lifestyle and sedentary women
Bressa, C., Bailén-Andrino, M., Pérez-Santiago, J., González-Soltero, R., Pérez, M., Montalvo-Lominchar, M. G., Maté-Muñoz, J. L., Domínguez, R., Moreno, D., & Larrosa, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171352 · Cited by 501
Lopresti, A. L. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx011 · Cited by 371
Metadata
- Authors
- Brahe, L. K., Astrup, A., & Larsen, L. H.
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 7
- Issue
- 1
- Pages
- 90-101
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- OpenAlex
- W2280501212
- Cited by
- 145
- References
- 54
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.